Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-05-18 @ 3:00 PM
Study NCT ID:
NCT02000102
Status:
COMPLETED
Last Update Posted:
2014-11-18
First Post:
2013-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
Sponsor:
Stanford University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetic Macular Edema | View |
Keywords: